Clinical Trials in Houston

Showing 12381-12400 of 17,885 trials

Pilot Study of X-82 in Patients With Wet AMD

NCT01674569

The objective of this study is to evaluate the safety and preliminary biologic activity/efficacy of X-82 in patients with wet Age-related Macular Degeneration (AMD). Preliminary efficacy will be assessed by change from baseline in visual acuity, fluorescein leakage, retinal thickness and fibrosis, if detectable, based on fundus examination, fundus photography, fluorescein angiography and optical coherence tomography (OCT).

Exudative Macular Degeneration

Tyrogenex35 participantsStarted Oct 2012

Beverly Hills, California, United States • New London, Connecticut, United States • Baltimore, Maryland, United States +2 more locations

TERMINATEDPhase 2< 1 mile

The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents

NCT00899678

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of certolizumab pegol treatment in pediatric subjects, aged 6 to 17, with moderately to severely active Crohn's disease. The target enrollment is 160 subjects.

Crohn's Disease

UCB Celltech99 participantsStarted Apr 2009

Phoenix, Arizona, United States • Los Angeles, California, United States • Orange, California, United States +32 more locations

Pilot Study of X-82 in Patients With Wet AMD

The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents

Find Trials by Condition in Houston

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old

SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.

A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]

Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay

M. D. Anderson Symptom Inventory - Ovarian Cancer

Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis

A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)

Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma

Shared Decision Making in the Emergency Department: Chest Pain Choice Trial

Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers

Mycotic Ulcer Treatment Trial I